Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $0.9103 is 93.68% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 0.9419||$ 2.91|
|Low:||$ 0.90||$ 0.47|
Company Description (as filed with the SEC)
Ritter Pharmaceuticals, Inc. develops novel therapeutic products that modulate the gut microbiome to treat digestive disorders and gastrointestinal diseases. Our lead product candidate, RP-G28, is an orally administered, high purity galacto-oligosaccharide ("GOS"), currently in Phase 3 clinical development for the treatment of lactose intolerance ("LI"), a condition that affects millions of people worldwide. RP-G28 is designed to selectively stimulate the growth of lactose-metabolizing bacteria in the colon, thereby effectively adapting the gut microbiome to assist in digesting lactose (the sugar found in milk) that reaches the large intestine. RP-G28 has the potential to become the first drug approved by the Food and Drug Administration ("FDA") for the treatment of LI. ... More ...
Nasdaq Official Price
Jun. 24, 2019
Jun. 24, 2019